the first genetically engineered fusion toxin to enter phase I trials as an anticancer agent
KeywordsChronic Lymphocytic Leukaemia Lymphocytic Leukaemia Partial Remission Interferon Gamma Diphtheria
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
© Adis International Ltd 1991